医学
抗磷脂综合征
补体系统
怀孕
免疫学
无花果素
类风湿性关节炎
效价
妊娠期
早产
凝集素途径
抗体
自身抗体
结缔组织病
内科学
前瞻性队列研究
产科
早产
生物标志物
红斑狼疮
风险因素
系统性红斑狼疮
自身免疫性疾病
结合珠蛋白
关节炎
抗体效价
免疫病理学
抗原
自身免疫
作者
Arianna Da Via,Maria O. Borghi,Laura Trespìdi,Lucia M. GHEZZI,Caterina Bodio,Claudia Grossi,Erika Carbone,Elena Raschi,Roberta Erra,Nicoletta Di Simone,Maria Gerosa,Federica Giulia Gazzola,Federica Locati,Roberto Felice Caporali,Irene Cetin,Chiara Lubrano,Roberta Bulla,Chiara Agostinis,Silvia Pegoraro,Francesco Tedesco
摘要
OBJECTIVE: Antiphospholipid antibodies (aPL) may directly affect placentation and trigger local complement-mediated inflammation/thrombosis. Obstetric complications in the antiphospholipid syndrome (APS) are still frequent despite therapy/close monitoring, and the identification of new risk biomarkers is an unmet need. We aimed to prospectively investigate the prognostic value of classification/nonclassification laboratory APS criteria and markers of complement activation for pregnancy complications, in particular preterm delivery (PTD). METHODS: We observed 60 women prospectively during pregnancy and postpartum: 33 aPL-positive (20 APS and 13 aPL-carriers) and 27 aPL-negative (5 systemic lupus erythematosus, 11 rheumatoid arthritis and 11 undifferentiated connective tissue diseases). aPL criteria tests, anti-phosphatidylserine/prothrombin (anti-PS/PT) IgG/IgM and anti-β2glycoprotein I-Domain I IgG, complement products (C3, C4, C3a, C5a, sC5b-9, MBL) and complement pathway activity (classical pathway [CP], alternative pathway [AP], and lectin pathway [LP]) were measured in 231 available specimens. RESULTS: PTD was experienced in 21% of aPL-positive and 15% of aPL-negative women. Anti-PS/PT IgG/IgM titers were significantly higher in PTD versus non-PTD women (P < 0.05) at almost all time points. At variance with CP and AP, LP activity in aPL-positive PTD was lower than in non-PTD, reaching a statistically significant difference compared with aPL-negative PTD patients (P < 0.05). Moreover, LP activity significantly correlated with anti-PS/PT IgG/IgM titers, both measured in the first trimester (P < 0.05), and all of them significantly correlated with the week of gestation at delivery (P < 0.05). CONCLUSION: The reduced LP activity and the higher anti-PS/PT IgG/IgM titers in PTD aPL-positive women during the first trimester suggest their use as early prognostic tools for PTD in aPL-positive pregnant women.
科研通智能强力驱动
Strongly Powered by AbleSci AI